Eris Lifesciences

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue335.49318.85415.32416.69327.84
Expenses225.26223.34282.79296.77293.20
EBITDA129.87115.75159.52151.4777.86
EBIT113.3798.47139.36126.4749.78
Profit Before Tax110.2395.51132.52119.9234.65
Net Profit99.3887.84110.74117.8131.66
Financial Ratios
Operating Profit Margin39.74%37.54%39.46%37.65%24.65%
Net Profit Margin30.41%28.49%27.39%29.29%10.02%
Earning Per Share (Diluted)7.316.438.138.652.33
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ